DR. AGARWAL'S EYE HOSPITAL LIMITED Dr. Agarwal's Eye Hospital Limited Stock
Equities
DRAGARWQ6
INE934C01018
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,511 INR | +0.26% |
|
-1.49% | +25.75% |
| May. 03 | Dr. Agarwal's Eye Hospital Opens New Branch in Tamil Nadu, India | MT |
| Apr. 25 | Dr. Agarwal's Eye Hospital's Consolidated Net Profit Drops in Fiscal Q4 | MT |
| Sales 2022 | 2.01B 24.14M | Sales 2023 | 2.68B 32.11M | Capitalization | 4.3B 51.56M |
|---|---|---|---|---|---|
| Net income 2022 | 241M 2.89M | Net income 2023 | 369M 4.42M | EV / Sales 2022 | 2.53 x |
| Net Debt 2022 | 1.65B 19.82M | Net Debt 2023 | 2.05B 24.58M | EV / Sales 2023 | 2.37 x |
| P/E ratio 2022 |
14.3
x | P/E ratio 2023 |
11.7
x | Employees | 974 |
| Yield 2022 |
0.41% | Yield 2023 |
0.33% | Free-Float | 23.66% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | +0.26% | ||
| 1 week | -1.49% | ||
| Current month | -0.46% | ||
| 1 month | +5.51% | ||
| 3 months | +21.44% | ||
| 6 months | +26.59% | ||
| Current year | +25.75% |
1 week
3 475.00
3 660.00
1 month
3 075.003 660.00
Current year
2 541.803 660.00
1 year
1 150.003 660.00
3 years
358.303 660.00
5 years
169.203 660.00
10 years
61.003 660.00
| Managers | Title | Age | Since |
|---|---|---|---|
Adil Agarwal
CEO | Chief Executive Officer | 40 | 19-06-02 |
Amar Agarwal
FOU | Founder | 63 | 94-04-21 |
Udhay Davey
DFI | Director of Finance/CFO | - | 20-12-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 22-06-22 | |
Amar Agarwal
FOU | Founder | 63 | 94-04-21 |
Anosh Agarwal
COO | Chief Operating Officer | 39 | 09-05-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 3,511 | +0.26% | 664 |
| 24-05-02 | 3,502 | -0.72% | 644 |
| 24-04-30 | 3,528 | +0.84% | 733 |
| 24-04-29 | 3,498 | -1.86% | 1,891 |
| 24-04-26 | 3,565 | +2.56% | 3,594 |
Delayed Quote Bombay S.E., May 03, 2024 at 06:00 am EDT
More quotes
Dr. Agarwal's Eye Hospital Limited an India-based company, which is primarily engaged in providing eye care and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
Calendar
2024-08-01
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +25.75% | 198M | |
| -18.46% | 16.57B | |
| +4.50% | 12.51B | |
| +4.31% | 11.69B | |
| +5.36% | 10.36B | |
| +24.72% | 8.38B | |
| -2.64% | 7.75B | |
| +20.04% | 7.16B | |
| +4.17% | 6.6B | |
| +46.90% | 4.54B |
- Stock Market
- Equities
- DRAGARWQ6 Stock
